Latest

When Omitted Contraindications Become a Pharmacovigilance Failure AIVO Journal — Sector Governance Analysis (Pharma & Life Sciences) Executive Summary AI assistants now provide medication guidance to patients and caregivers at scale, often before consultation with healthcare professionals or review of approved labeling. These systems are not neutral information channels. They actively

Why Continuous AI Exposure Creates a Continuous Supervisory Duty AIVO Journal — Governance Commentary Large language models now operate as continuous public-facing decision surfaces. They generate recommendations, comparisons, exclusions, and explanations about regulated products and services at all hours, across jurisdictions, languages, and user contexts. These outputs increasingly shape consumer

Why Enterprises Cannot Disclaim Consumer Harm Caused by LLM “Optimization” AIVO Journal — Governance Commentary Enterprises are increasingly using LLM optimization platforms to shape how their brands, products, and services appear inside AI-generated answers. These systems promise improved visibility across conversational interfaces that enterprises do not control. What is less

AIVO Journal — Governance Analysis The emerging failure mode Enterprise AI risk discussions remain dominated by questions of accuracy, bias, hallucination, and model safety. These concerns are legitimate, but they obscure a quieter and more immediate failure mode that is already materialising across industries: AI-generated claims are being relied upon

Decision-Shaped AI Reasoning as an Immediate Governance Exposure in Regulated Healthcare Contexts AIVO Journal - Anonymised Governance Case Study Executive Framing (for Risk and Finance Leadership) This case study examines a class of AI risk that is already operational, externally generated, and materially ungoverned: decision-shaped AI output produced under

AIVO Journal — Governance Commentary As AI systems become operationally influential, the central risk is no longer whether they can generate fluent answers. It is whether their reasoning can be inspected after the fact. Enterprises are now routinely affected by external AI systems they do not control: large language models mediating

AIVO Journal — Sector Governance Series AI assistants now influence how patients, clinicians, caregivers, and even regulators understand medicines, devices, indications, contraindications, risks, and clinical options. These systems answer questions long before individuals reach official channels. They often shape expectations about treatment pathways, benefit risk profiles, safety considerations, and comparative options.